O-4 - Antimicrobial Stewardship in Special Populations/Non-Acute Care

Co-Author(s)

• RA

  Roy Ahn, MPH, ScD

  Vice President, Public Health
  NORC
  Chicago, Illinois

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• DA

  Deborah Aragon, MSPH

  Infection Preventionist
  Denver Health Medical Center
  Denver, Colorado

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• KB

  Kim Brunisholz, PhD

  Dr.
  Intermountain Healthcare
  Salt Lake City, Utah

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Whitney Buckel, Pharm D

  System Antimicrobial Stewardship Pharmacist Manager
  Intermountain Healthcare
  Salt Lake City, Utah

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SC

  Sara E Cosgrove, MD, MS

  Professor of Medicine, Division of Infectious Diseases
  Johns Hopkins University of Medicine
  Baltimore, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• PD

  Prashila Dullabh, MD

  Senior Fellow
  NORC at the University of Chicago
  Bethesda, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MD

  Michael Durkin, MD, MPH

  Assistant Professor of Medicine
  Washington University
  St. Louis, Missouri

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Charlesnika Evans, PhD, MPH

  Associate Professor and Research Health Scientist
  Preventive Medicine
  Northwestern University and VA
  Hines, Illinois

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• NF

  Nora Fino, MS

  Biostatistician II
  Division Of Epidemiology
  University of Utah
  Salt Lake City, Utah

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• YG

  Yue Gao, MPH

  Sr Research Scientist
  NORC
  Bethesda, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SH

  S. Ann Holmes, MD

  Associate Professor
  Baylor College of Medicine
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• TJ

  Timothy Jenkins, MD

  Associate Professor
  Infectious Diseases, Medicine
  Denver Health Medical Center, University of Colorado School of Medicine
  Denver, Colorado

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Robin Jump, MD, PhD

  Associate Professor of Medicine
  Department of Medicine
  Case Western Reserve University
  Cleveland, Ohio

  Disclosure: Merck : Research Grant or Support (Status: Ongoing); Pfizer () : Advisor or Review Panel member, Research Grant or Support
• MK

  Matthew Keller, MS

  Database Adminstrator
  Washington University in St. Louis
  St. Louis, Missouri

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Bryan Knepper, MPH, MS

  Infection Control Manager
  Patient Safety and Quality
  Denver Health Medical Center
  Denver, CO

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• NK

  Naresh Kumar, MPH

  Project Manager
  Acute Care Research
  Intermountain Healthcare
  Salt Lake City, Utah

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• YM

  Yinjiao Ma, MS, MPH

  Statistical Data Analyst
  Washington University
  St. Louis, Missouri

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• SM

  Sarah May, MS, MPH

  Research Coordinator
  Medicine-Health Services Research
  Baylor College of Medicine
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MM

  Melissa Miller, MD, MS

  Physician
  Center for Quality Improvement and Patient Safety
  Agency for Healthcare Research and Quality
  Rockville, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MO

  Margaret Olsen, PhD, MPH

  Professor
  Medicine
  Washington University in St. Louis
  St. Louis, Missouri

  Disclosure: Merck (Grant/Research Support)Pfizer (Consultant, Grant/Research Support)
• IP

  Ivy Poon, PharmD

  Professor
  Texas Southern University
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• WP

  William Powderly, MD

  J. William Campbell Professor of Medicine
  Division of Infectious Diseases Washington University in St. Louis
  St. Louis, Missouri

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Theresa Rowe, DO MS

  Assistant Professor of Medicine
  Northwestern University
  Chicago, Illinois

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• MS

  Matthew Samore, MD

  Director
  IDEAS Center
  VA Salt Lake City Healthcare System
  Salt Lake City, Utah

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• ES

  Erik Scherpf, Ph.D.

  Senior Research Methodogist
  NORC at the University of Chicago
  Arlington, Virginia

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Katherine Shihadeh, PharmD

  Clinical Pharmacist Specialist, Infectious Diseases
  Pharmacy
  Denver Health Medical Center
  Denver, Colorado

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• KS

  Kathleen Speck, MPH

  Research Project Administrator
  Johns Hopkins
  Baltimore, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• RS

  Rajendu Srivastava, MD

  Dr.
  Intermountain Healthcare
  Salt Lake City, Utah

  Disclosure: AHRQ, NIH, CDC (Grant/Research Support, I hold grants from AHRQ, NIH and CDC for a variety of clinical research and implementation studies)IPASS Patient Safety Institute (Other Financial or Material Support, I am a physician founder of this company to spread handoff best practices and reduce adverse events. My employer holds my equity in this company.)
• 

  Eddie Stenehjem, MD, MSc

  Medical Director, Antibiotic Stewardship
  Office of Patient Experience
  Intermountain Healthcare
  Salt Lake City, UT

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Pranita Tamma, MD, MHS

  Associate Professor
  Johns Hopkins
  Baltimore, Maryland

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• 

  Barbara Trautner, MD, PhD

  Professor of Medicine
  Infectious Disease
  Michael E DeBakey VA Medical Center
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AW

  Annette Walder, MS

  Statistician
  Center for Innovations in Quality, Effectiveness and Safety
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• AW

  Anthony Wallin, MD

  Dr.
  Intermountain Healthcare
  Salt Lake City, Utah

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
• PW

  Park Willis, MD

  Dr.
  Intermountain Healthcare
  Salt Lake City, Utah

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presenting Author(s)

• 

  Anne Butler, PhD

  Assistant Professor
  Washington University in St. Louis
  St. Louis, MO

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• AH

  Adam Hersh, MD, PhD

  Pediatric Infectious Diseases Physician
  University of Utah
  Salt Lake City, UT

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Morgan Katz, MD, MHS

  Assistant Professor
  Johns Hopkins University
  Baltimore, Maryland

  Disclosure: AHRQ : Research Grant or Support; CDC : Grant/Research Support (Status: Ongoing), Research Grant or Support (Status: Ongoing)

  Slides Slides and Audio
• 

  Felicia Skelton, MD, MS

  Assistant Professor
  Baylor College of Medicine
  Houston, Texas

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio
• 

  Axel Vazquez Deida, PharmD

  MPH Student, Epidemiology
  Department of Pharmacy Services
  University of Nebraska Medical Center
  Tucson, AZ

  Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.

  Slides Slides and Audio

Presentations:

• outcomes from the AHRQ Safety Program for Improving Antibiotic Use Across 439 Long-term Care Facilities
  Morgan Katz, MD, MHS – Johns Hopkins University; Theresa Rowe, DO MS – Northwestern University; Sara E Cosgrove, MD, MS – Johns Hopkins University of Medicine; Pranita Tamma, MD, MHS – Johns Hopkins; Melissa A. Miller, MD, MS – Agency for Healthcare Research and Quality; Prashila Dullabh, MD – NORC at the University of Chicago; Kathleen Speck, MPH – Johns Hopkins; Roy Ahn, MPH, ScD – NORC; Yue Gao, MPH – NORC; Erik Scherpf, Ph.D. – NORC at the University of Chicago; Robin L. Jump, MD, PhD – Case Western Reserve University
• Leveraging Data to Explore the Consequences of Urine Testing and Antibiotic Use During the Spinal Cord Injury Annual Evaluation
  Sarah B. May, MS, MPH – Baylor College of Medicine; Annette Walder, MS – Center for Innovations in Quality, Effectiveness and Safety; S. Ann Holmes, MD – Baylor College of Medicine; Ivy Poon, PharmD – Texas Southern University; Charlesnika T. Evans, PhD, MPH – Northwestern University and VA; Barbara Trautner, MD, PhD – Michael E DeBakey VA Medical Center; Felicia Skelton, MD, MS – Baylor College of Medicine
• SCORE-UC: Antibiotic Stewardship in Urgent Care
  Adam Hersh, MD, PhD – University of Utah; Eddie Stenehjem, MD, MSc – Intermountain Healthcare; Nora Fino, MS – University of Utah; Park Willis, MD – Intermountain Healthcare; Rajendu Srivastava, MD – Intermountain Healthcare; Whitney R. Buckel, Pharm D – Intermountain Healthcare; Kim Brunisholz, PhD – Intermountain Healthcare; Anthony Wallin, MD – Intermountain Healthcare; Naresh Kumar, MPH – Intermountain Healthcare; Matthew H. Samore, MD – VA Salt Lake City Healthcare System
• Comparative Safety of Antibiotic Therapy for Outpatient Treatment of Uncomplicated Urinary Tract Infections
  Anne Mobley Butler, PhD – Washington University in St. Louis; Michael Durkin, MD, MPH – Washington University; Matthew R. Keller, MS – Washington University in St. Louis; Yinjiao Ma, MS, MPH – Washington University; William Powderly, MD – Division of Infectious Diseases Washington University in St. Louis; Margaret A. Olsen, PhD, MPH – Washington University in St. Louis
• Durations of Antibiotic Therapy and Factors Associated with Longer Than Recommended Durations for Common Ambulatory Infections in an Integrated Healthcare System
  Axel A. Vazquez Deida, PharmD – University of Nebraska Medical Center; Katherine C. Shihadeh, PharmD – Denver Health Medical Center; Deborah Aragon, MSPH – Denver Health Medical Center; Bryan C. Knepper, MPH, MS – Denver Health Medical Center; Timothy C. Jenkins, MD – Denver Health Medical Center, University of Colorado School of Medicine